Physician

Kristen Rainear, D.O.

According to 2025 Medicare claims, Kristen Rainear, D.O. (NPI: 1689662165) practices cardiology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (NPI: 1124122387; TIN: 232865181) and primary practice location at 08360-5843. Rainear is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Rainear's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,131 traditional Medicare patients, billed 6,080 HCPCS/CPT codes, and received $341,054 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 10,626 prescription claims across 1,171 beneficiaries totaling $2,446,358 in drug costs, led by Xarelto (Rivaroxaban). 2023 DME data shows 14 claims. Open Payments data shows 36 records totaling $417. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $549,740 to $341,054. In contrast, Part D prescription costs have moved sharply higher in recent years, from $762,964 to $2,446,358. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $19,232 and ending at $33,725.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,636	8,226	$549,740
2016	2,068	8,999	$588,646
2017	1,844	7,957	$520,596
2018	1,848	7,573	$489,473
2019	1,642	7,102	$479,000
2020	1,224	5,428	$384,527
2021	1,234	5,878	$417,467
2022	1,168	5,755	$410,304
2023	1,249	5,738	$363,254
2024	1,131	6,080	$341,054

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	759	6,413	$762,964
2016	829	7,185	$840,252
2017	857	6,996	$786,649
2018	905	7,183	$809,287
2019	955	7,936	$1,075,910
2020	991	9,281	$1,381,927
2021	1,058	9,741	$1,629,233
2022	1,084	10,252	$2,022,315
2023	1,120	10,488	$2,392,435
2024	1,171	10,626	$2,446,358

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	70	$6,712
2016	11	71	$4,724
2017	N/R	113	$4,561
2018	N/R	77	$32,719
2019	N/R	35	$1,813
2020	N/R	56	$3,712
2021	N/R	69	$4,305
2022	N/R	48	$2,888
2023	N/R	14	$33,299
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	328	344	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	607	889	$93
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	560	902	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	688	1,098	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	328	388	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xarelto	Rivaroxaban	462	34,012	$608,559
Entresto	Sacubitril/Valsartan	358	23,929	$508,750
Eliquis	Apixaban	392	23,260	$430,780
Repatha Sureclick	Evolocumab	227	12,930	$240,948
Jardiance	Empagliflozin	96	6,579	$123,180

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$417	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristen Rainear, D.O.?

Tedicare shows public-source Medicare data for Kristen Rainear, D.O. (NPI 1689662165), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristen Rainear, D.O. have ACO affiliation data?

Kristen Rainear, D.O. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Kristen Rainear, D.O.?

Kristen Rainear, D.O. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY PC (billing NPI 1124122387) in the available physician profile data.

Does Kristen Rainear, D.O. have Open Payments data?

Kristen Rainear, D.O. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.